Testing XmAb942 against a placebo for ulcerative colitis (UC)
Explore this study →
There are 6 groups in this study. Groups A, C and E, the comparison group, receive XmAb942. Groups B, D and F, the placebo group, receive Placebo.
Sites in London, Montreal and 2 more cities
- Phase 1
- 6 groups
- Sites in London, Montreal and 2 more cities
- Recruiting
Official title: Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Ulcerative Colitis (UC) · Xencor, Inc.